Research ArticleClinical Studies

Long-term Results of a Phase II Study of S-1 plus Irinotecan in Metastatic Colorectal Cancer

SATORU IWASA, YASUHIDE YAMADA, KEN KATO, AYUMU GOTO, YOSHITAKA HONMA, TETSUYA HAMAGUCHI and YASUHIRO SHIMADA
Anticancer Research September 2012, 32 (9) 4157-4161;

Article Information

vol. 32 no. 9 4157-4161
PMID 
22993378
Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received June 28, 2012
  • Revision received August 7, 2012
  • Accepted August 8, 2012
  • Published online September 18, 2012.
Copyright & Usage 
Copyright© 2012 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. SATORU IWASA1,
  2. YASUHIDE YAMADA1⇓,
  3. KEN KATO1,
  4. AYUMU GOTO2,
  5. YOSHITAKA HONMA1,
  6. TETSUYA HAMAGUCHI1 and
  7. YASUHIRO SHIMADA1
  1. 1Gastrointestinal Oncology Division, National Cancer Center Hospital, Tokyo, Japan
  2. 2Department of Clinical Oncology, Yokohama City University Graduate School of Medicine, Yokohama, Japan
  1. Correspondence to: Yasuhide Yamada, Gastrointestinal Oncology Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan. Tel: +81 335422511, Fax: +81 335423815, e-mail: yayamada{at}ncc.go.jp
View Full Text

Statistics from Altmetric.com

Cited By...

Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Long-term Results of a Phase II Study of S-1 plus Irinotecan in Metastatic Colorectal Cancer
SATORU IWASA, YASUHIDE YAMADA, KEN KATO, AYUMU GOTO, YOSHITAKA HONMA, TETSUYA HAMAGUCHI, YASUHIRO SHIMADA
Anticancer Research Sep 2012, 32 (9) 4157-4161;
Twitter logo Facebook logo Mendeley logo

Jump to section